Northwest Biotherapeutics (NWBO) Amortizatization of Intangibles (2010 - 2017)
Northwest Biotherapeutics' (NWBO) quarterly Amortizatization of Intangibles came in at $358000.0 in Q4 2017, up 69.67% year-on-year from $211000.0 in Q4 2016, and up 3.77% quarter-over-quarter from $345000.0 in Q3 2017.
Northwest Biotherapeutics (NWBO) Amortizatization of Intangibles (2010 - 2017) Analysis & Trends
Northwest Biotherapeutics' Amortizatization of Intangibles history runs 8 years deep, the most recent figure standing at $358000.0 for Q4 2017.
- On a quarterly basis, Amortizatization of Intangibles rose 69.67% year-over-year to $358000.0 in Q4 2017; TTM through Dec 2017 was $1.3 million, a 201.43% increase from a year earlier, with the FY2020 full-year figure at $122000.0, up 320.69% from the prior year.
- Amortizatization of Intangibles grew to $358000.0 in Q4 2017 per NWBO's latest filing, from $345000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $373000.0 in Q1 2017 and bottomed at -$71000.0 in Q4 2014.
- The 5-year median for Amortizatization of Intangibles is $190000.0 (2017), against an average of $174923.1.
- Biggest YoY gain for Amortizatization of Intangibles was 373.33% in 2014; the steepest drop was 308.82% in 2014.
- Year by year, Amortizatization of Intangibles stood at $34000.0 in 2013, then slumped by 308.82% to -$71000.0 in 2014, then jumped by 180.28% to $57000.0 in 2015, then soared by 270.18% to $211000.0 in 2016, then soared by 69.67% to $358000.0 in 2017.
- Per Business Quant, the three latest NWBO Amortizatization of Intangibles figures stand at $358000.0 (Q4 2017), $345000.0 (Q3 2017), and $190000.0 (Q2 2017).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Northwest Biotherapeutics | 272.75 Mn | 270.97 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 358,000.00 |
| Dec 31, 2017 | 358,000.00 |
| Sep 30, 2017 | 345,000.00 |
| Sep 30, 2017 | 345,000.00 |
| Jun 30, 2017 | 190,000.00 |
| Jun 30, 2017 | 190,000.00 |
| Mar 31, 2017 | 373,000.00 |
| Mar 31, 2017 | 373,000.00 |
| Dec 31, 2016 | 211,000.00 |
| Dec 31, 2016 | 211,000.00 |
| Mar 31, 2016 | 209,000.00 |
| Mar 31, 2016 | 209,000.00 |
| Dec 31, 2015 | 57,000.00 |
| Dec 31, 2015 | 57,000.00 |
| Dec 31, 2014 | -71,000.00 |
| Dec 31, 2014 | -71,000.00 |
| Sep 30, 2014 | 71,000.00 |
| Sep 30, 2014 | 71,000.00 |
| Dec 31, 2013 | 34,000.00 |
| Dec 31, 2013 | 34,000.00 |